211 related articles for article (PubMed ID: 8428367)
1. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
[TBL] [Abstract][Full Text] [Related]
2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
3. Experimental gene therapy of human colon cancer.
Bold RJ; Warren RE; Ishizuka J; Cho-Chung YS; Townsend CM; Thompson JC
Surgery; 1994 Aug; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
[TBL] [Abstract][Full Text] [Related]
4. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH
Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.
Tortora G; Pepe S; Cirafici AM; Ciardiello F; Porcellini A; Clair T; Colletta G; Cho-Chung YS; Bianco AR
Cell Growth Differ; 1993 May; 4(5):359-65. PubMed ID: 8518230
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
Tagliaferri P; Katsaros D; Clair T; Ally S; Tortora G; Neckers L; Rubalcava B; Parandoosh Z; Chang YA; Revankar GR
Cancer Res; 1988 Mar; 48(6):1642-50. PubMed ID: 2830966
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V
Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
[TBL] [Abstract][Full Text] [Related]
9. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
Cho YS; Cho-Chung YS
Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
[TBL] [Abstract][Full Text] [Related]
10. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.
Tortora G; Yokozaki H; Pepe S; Clair T; Cho-Chung YS
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):2011-5. PubMed ID: 2000408
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cyclic AMP-dependent protein kinase gene expression during ontogeny of the murine palate.
Greene RM; Lloyd MR; Uberti M; Nugent P; Pisano MM
J Cell Physiol; 1995 Jun; 163(3):431-40. PubMed ID: 7775586
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
Alper O; Hacker NF; Cho-Chung YS
Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
[TBL] [Abstract][Full Text] [Related]
14. Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells.
Yokozaki H; Tortora G; Pepe S; Maronde E; Genieser HG; Jastorff B; Cho-Chung YS
Cancer Res; 1992 May; 52(9):2504-8. PubMed ID: 1314695
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV; Cho-Chung YS
Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and cell-specific expression of newly discovered subunits of cAMP-dependent protein kinases. Implications for different cellular responses to cAMP.
Oyen O; Sandberg M; Levy FO; Taskén K; Beebe S; Hansson V; Jahnsen T
APMIS Suppl; 1988; 2():238-50. PubMed ID: 2846017
[TBL] [Abstract][Full Text] [Related]
18. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclic AMP-triggered aromatase gene expression in human choriocarcinoma cells by antisense oligodeoxynucleotide.
Ackermann K; Fauss J; Pyerin W
Cancer Res; 1994 Sep; 54(18):4940-6. PubMed ID: 8069860
[TBL] [Abstract][Full Text] [Related]
20. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects.
Tortora G; Clair T; Cho-Chung YS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):705-8. PubMed ID: 1689049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
